Extremely positive. Pre-clinical still, but these results show precisely why OmniCAR is such a revolution in the improvement of CAR-T therapies. It really is the cat amongst the pigeons.
Now if OmniCAR could be used in combo with Imugene's OnCARlytics.....
Two of the most remarkable developments in cancer treatment, both of them held by Australian Biotechs.
22c for PTX is incredibly cheap in my view, based on OmniCAR alone, and they have much more. It's like buying Imugene a year ago, and if you didn't, I bet you now wish you did....
